Potent and Selective Covalent Quinazoline Inhibitors of KRAS G12C.
Zeng, M., Lu, J., Li, L., Feru, F., Quan, C., Gero, T.W., Ficarro, S.B., Xiong, Y., Ambrogio, C., Paranal, R.M., Catalano, M., Shao, J., Wong, K.K., Marto, J.A., Fischer, E.S., Janne, P.A., Scott, D.A., Westover, K.D., Gray, N.S.(2017) Cell Chem Biol 24: 1005-1016.e3
- PubMed: 28781124 
- DOI: 10.1016/j.chembiol.2017.06.017
- Primary Citation of Related Structures:  
5V9L, 5V9O - PubMed Abstract: 
Targeted covalent small molecules have shown promise for cancers driven by KRAS G12C. Allosteric compounds that access an inducible pocket formed by movement of a dynamic structural element in KRAS, switch II, have been reported, but these compounds require further optimization to enable their advancement into clinical development ...